# A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

> **NCT07082829** · PHASE1 · RECRUITING · sponsor: **Centessa Pharmaceuticals (UK) Limited** · enrollment: 208 (estimated)

## Conditions studied

- Excessive Daytime Sleepiness

## Interventions

- **DRUG:** ORX142 Tablets
- **OTHER:** Placebo Tablets

## Key facts

- **NCT ID:** NCT07082829
- **Lead sponsor:** Centessa Pharmaceuticals (UK) Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-30
- **Primary completion:** 2026-06-15
- **Final completion:** 2026-06-15
- **Target enrollment:** 208 (ESTIMATED)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07082829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07082829, "A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07082829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*